Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH-797804 in moderate to severe COPD
2007-004466-41Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2007
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PH-797804 in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Pfizer. Primary endpoint: Change from baseline in trough FEV1. Started Nov 2007; status: completed.
02
Drugs
PH-797804
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2007-004466-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004466-41.